Index of medicine substances

Tocopherol  •  Alimentary tract and metabolism | Other plain vitamin preparations (A11HA03)

Tofacitinib  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Janus-associated kinase (JAK) inhibitors (L04AF01)

Tofersen  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX22)

Tofisopam  •  Nervous system | Anxiolytics | Benzodiazepine derivatives (N05BA23)

Tolbutamide  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas (A10BB03)

Tolcapone  •  Nervous system | Dopaminergic agents | Other dopaminergic agents (N04BX01)

Tolfenamic acid  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Fenamates (M01AG02)

Tolnaftate  •  Dermatologicals | Antifungals for topical use | Other antifungals for topical use (D01AE18)

Tolperisone  •  Musculo-skeletal system | Muscle relaxants | Muscle relaxants, centrally acting agents | Other centrally acting agents (M03BX04)

Tolterodine  •  Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs for urinary frequency and incontinence (G04BD07)

Tolvaptan  •  Cardiovascular system | Other diuretics | Vasopressin antagonists (C03XA01)

Topiramate  •  Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX11)

Topotecan  •  Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Topoisomerase 1 (TOP1) inhibitors (L01CE01)

Torasemide  •  Cardiovascular system | High-ceiling diuretics | Sulfonamides, plain (C03CA04)

Toremifene  •  Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens (L02BA02)

Toripalimab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors (L01FF13)

Tovorafenib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | B-raf serine-threonine kinase (BRAF) inhibitors (L01EC04)

Tozinameran + COVID-19 mRNA vaccine (with modified nucleosides)  •  Antiinfectives for systemic use | Viral vaccines | Other viral vaccines (J07BX03)

Tozinameran/riltozinameran Covid-19 mRNA vaccine (with modified nucleosides)  •  Antiinfectives for systemic use | Viral vaccines | Other viral vaccines (J07BX03)

Trabectedin  •  Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Other plant alkaloids and natural products (L01CX01)

Tralokinumab  •  Dermatologicals | Other dermatological preparations | Other dermatological preparations | Agents for dermatitis, excluding corticosteroids (D11AH07)

Tramadol  •  Nervous system | Opioids | Other opioids (N02AX02)

Tramadol + dexketoprofen  •  Nervous system | Opioids | Opioids in combination with non-opioid analgesics (N02AJ14)

Tramadol + paracetamol  •  Nervous system | Opioids | Opioids in combination with non-opioid analgesics (N02AJ13)

Tramazoline  •  Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, plain (R01AA09)

Trametinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Mitogen-activated protein kinase (MEK) inhibitors (L01EE01)

Trandolapril  •  Cardiovascular system | Ace inhibitors, plain (C09AA10)

Tranexamic acid  •  Blood and blood forming organs | Antifibrinolytics | Amino acids (B02AA02)

Trastuzumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors (L01FD01)

Trastuzumab deruxtecan  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors (L01FD01)